United States · Series E startup
2 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$31Mraised across 2 rounds since 2001, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
New Enterprise Associates
Domain Associates
Boston Scientific
Catalyst Venture Partners
Lovett Miller & Co.From a historical funding record
New Enterprise AssociatesDomain AssociatesCatalyst Venture PartnersLovett Miller & Co.From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Proxima Therapeutics's investors include New Enterprise Associates, Domain Associates, Merrill Lynch Ventures, Catalyst Venture Partners and Lovett Miller & Co., and 5 more on record.
Proxima Therapeutics has raised $31M across 2 rounds since 2001.
Proxima Therapeutics's most recent round was a Series E of $14M in Aug 2002.
Proxima Therapeutics's largest round on record is $17M (Series D), in Feb 2001.
Proxima Therapeutics's first round on record, in Feb 2001, was backed by New Enterprise Associates, Domain Associates and Merrill Lynch Ventures and 4 others.
Proxima Therapeutics's latest named round is a Series E, in Aug 2002.
Proxima Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·